SCHEMBL6504227

SCHEMBL6504227

CC(C)(C)c1ccc2c(c1)[C]2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
TDP1 Q9NUW8 2/20 0.44
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MAPT P10636 2/20 0.40
MEN1 O00255 1/20 0.40
GAA P10253 1/20 0.40
PKM P14618 1/20 0.40
RECQL P46063 1/20 0.40
KMT2A Q03164 1/20 0.40
TSHR P16473 1/20 0.40
LMNA P02545 1/20 0.39
TYR P14679 1/20 0.39
NPC1 O15118 1/20 0.38
PLA2G1B P04054 1/20 0.38
NFKB1 P19838 1/20 0.38
CASP3 P42574 1/20 0.38
RAB9A P51151 1/20 0.38
NFKB2 Q00653 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7947574 0.83 ALDH1A1 (0.45) ALDH1A1TDP1HPGDALOX15HSD17B10
SCHEMBL8086154 0.74 ALDH1A1 (0.52) ALDH1A1TDP1HPGDALOX15HSD17B10
SCHEMBL424728 0.67 TSHR (0.73) ALDH1A1TDP1HPGDALOX15HSD17B10
SCHEMBL30010382 0.67 ALDH1A1 (0.52) ALDH1A1TDP1HPGDALOX15HSD17B10
SCHEMBL348347 0.67 ALDH1A1 (0.52) ALDH1A1TDP1HPGDALOX15HSD17B10
SCHEMBL1450324 0.66 ALDH1A1 (0.36) ALDH1A1TDP1HPGDALOX15HSD17B10
SCHEMBL2009857 0.65 TSHR (0.52) ALDH1A1TDP1HPGDALOX15HSD17B10
SCHEMBL1134715 0.65 ALDH1A1 (0.58) ALDH1A1TDP1HPGDALOX15HSD17B10
SCHEMBL7521505 0.65 ALDH1A1 (0.50) ALDH1A1TDP1HPGDALOX15HSD17B10
SCHEMBL1134700 0.65 ALDH1A1 (0.58) ALDH1A1TDP1HPGDALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005019200-A2 ARYL PIPERIDINE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-03-03 WO disclosed